# TUDCA - Clinical Longevity Review & Consensus Audit

> **Consensus Verdict**: Tauroursodeoxycholic Acid (TUDCA) is a hydrophilic tertiary bile acid and first-in-class chemical chaperone that directly resolves Endoplasmic Reticulum (ER) stress and proteotoxic unfolded protein accumulation. In gold-standard human hyperinsulinemic-euglycemic clamp trials, TUDCA improved muscle and liver insulin sensitivity by ~30%, normalized hepatic transaminases, and prevented mitochondrial outer membrane permeabilization (MOMP).

## 1. Executive Summary & Scores
- **Longevity Evidence Score**: **89/100**
- **Evidence Quality Tier**: **silver**
- **Human Clinical Evidence Strength**: 90/100
- **Primary Longevity Classification**: supplements
- **Safety Margin Score**: 89/100 (Higher is safer)
- **Time Burden**: ~1 minutes/day
- **Estimated Monthly Cost**: moderate
- **Adherence Friction**: 3/10 (Lower is easier to sustain)

---

## 2. Biological Mechanisms of Action
TUDCA (Tauroursodeoxycholic Acid ER Stress Reduction)Tauroursodeoxycholic acid (TUDCA) is a highly hydrophilic bile acid that serves as a powerful chemical chaperone. TUDCA stabilizes the membrane of the endoplasmic reticulum (ER), preventing the accumulation of unfolded proteins that trigger the Unfolded Protein Response (UPR) and subsequent cellular apoptosis38. By mitigating ER stress, a protocol of 250mg-500mg of TUDCA taken twice daily with meals protects hepatocytes and neurological tissue from metabolic damage, while ensuring optimal biliary flow and fat-soluble nutrient absorption40. It acts to thin viscous bile, alleviating gastrointestinal distress and supporting liver detoxification pathways41.

---

## 3. Canonical Longevity Vector Impacts (The 8 Longevity Pillars)
- **Heart Health & Endothelial Function**: **42/100** [Rank #121 of 133 in Heart] - Effect: Moderate (Endothelial ER stress alleviation and vascular cytoprotection)
    - Mechanism: Reduces endoplasmic reticulum stress in vascular endothelial cells, preventing hyperhomocysteinemia-induced endothelial apoptosis.
- **Brain Longevity & Neuroprotection**: **60/100** [Rank #107 of 141 in Brain] - Effect: Moderate-Strong (Crosses blood-brain barrier, inhibits neuronal apoptosis)
    - Mechanism: Readily penetrates the blood-brain barrier, preserves mitochondrial membrane integrity against misfolded amyloid oligomers, and inhibits caspases.
- **Metabolic Flexibility & Glycemic Control**: **78/100** [Rank #31 of 129 in Metabolic] - Effect: Strong (+30% Muscle and Hepatic Insulin Sensitivity in Human Clamp Trials)
    - Mechanism: Acts as a chemical chaperone in the ER lumen, suppressing the unfolded protein response (UPR) in hepatocytes and myocytes to restore insulin receptor substrate-1 (IRS-1) signaling.
- **Cancer Defense & DNA Repair**: **25/100** [Rank #79 of 120 in Cancer Defense] - Effect: Mild (Protective against secondary bile acid mutagenesis)
    - Mechanism: Hydrophilic bile acid that competitively displaces toxic, detergent-like hydrophobic bile salts (deoxycholic acid) in the colon.
- **Endocrine & Anabolic Balance**: **0/100** [Rank #92 of 120 in Endocrine] - Effect: Neutral
    - Mechanism: Bile acid chaperone with neutral steroidogenic impact.
- **Chronic Inflammation Reduction**: **55/100** [Rank #108 of 126 in Inflammation] - Effect: Moderate (Suppresses NLRP3 inflammasome activation triggered by ER stress)
    - Mechanism: Inhibits cellular ER stress-induced calcium leakage into the cytosol, preventing mitochondrial ROS generation and subsequent NLRP3 inflammasome assembly.
- **Bone Density & Connective Matrix**: **0/100** [Rank #115 of 142 in Bone Matrix] - Effect: Neutral
    - Mechanism: Zero direct osteogenic mechanical stimulus.
- **Cellular Longevity & Autophagy**: **82/100** [Rank #52 of 131 in Cellular] - Effect: Strong (First-in-class Endoplasmic Reticulum chemical chaperone & MOMP inhibitor)
    - Mechanism: Binds exposed hydrophobic regions of nascent unfolded polypeptides in the ER to promote proper refolding and prevents pro-apoptotic Bax translocation to mitochondria.

---

## 4. Practical Protocol & Administration Guidelines
- **Standard Clinical Dosage**: 250-500mg
- **Recommended Timing**: With meals
- **Administration Type**: supplement
- **Recommended Biomarkers to Monitor**: digestive_comfort, cellular_longevity, metabolic_health, bone_density, heart_health, testosterone

---

## 5. Safety, Contraindications & Drug Interactions
- **Contraindications**: Complete biliary tract obstruction, Acute cholecystitis, Severe intrahepatic cholestasis
- **Safety Profile**: low_risk - Transient osmotic diarrhea at doses >1500mg/day; Mild abdominal discomfort

---

## 6. Peer-Reviewed Human Clinical Trials & Key PMIDs
1. **The chemical chaperone TUDCA: Therapeutic potential in metabolic and ER stress pathologies** [PMID: 24817109]
   - Link: https://pubmed.ncbi.nlm.nih.gov/24817109/
2. **Bile acid chaperone therapy attenuates lipid accumulation in hepatocytes and improves circulating aminotransferases** [PMID: 15531477]
   - Link: https://pubmed.ncbi.nlm.nih.gov/15531477/
3. **Tauroursodeoxycholic Acid improves liver and muscle insulin sensitivity in obese humans** [PMID: 20587723]
   - Link: https://pubmed.ncbi.nlm.nih.gov/20587723/

---

## 7. Canonical Citation & Web Verification
- **Official Web Review**: [TUDCA on LongevityReviews](https://longevityreviews.org/modalities/tudca)
- **Last Evidence Calibration**: 2026-09-09
- **Review Policy**: 0% sponsored placements, independent peer-reviewed consensus.